Impact of Copper and Zinc Levels on Ischemic Heart Disease: A Genetic Study

Study Overview

A recent study employed genetic analysis to explore the relationship between copper and zinc levels and the risk of ischemic heart disease. The findings indicate that higher copper levels may reduce disease risk, while increased zinc levels may elevate it.

Understanding Ischemic Heart Disease

Ischemic heart disease is responsible for nearly 13% of global deaths, making it the leading cause of mortality worldwide. Also known as coronary artery disease, it occurs when the coronary arteries are obstructed, resulting in inadequate oxygen supply to the heart. This can lead to symptoms such as chest pain, heart attacks, or chronic heart failure.

The Challenge of Researching Metal Exposure

Researchers have speculated that exposure to copper or zinc could influence the likelihood of developing ischemic heart disease. However, conducting experimental studies in humans poses challenges. This is largely due to the strong association between the sources of copper and zinc exposure and socioeconomic status, which is also linked to higher disease prevalence, complicating the ability to isolate these factors.

Innovative Research Methodology

To address these challenges, a team of American researchers devised an innovative approach. Instead of examining dietary or environmental exposure directly, they focused on genetic traits associated with varying levels of these metals in the bloodstream. They then analyzed whether individuals with specific genetic traits were at increased or decreased risk for ischemic heart disease. The findings were published in The American Journal of Clinical Nutrition.

Utilizing Genome-Wide Association Studies

Genome-wide association studies (GWAS) are essential for identifying genetic variants related to various traits, including disease susceptibility. These studies concentrate on specific genomic regions known to exhibit variability among individuals, rather than sequencing the entire genome, which can be labor-intensive and costly.

Research Findings

The researchers utilized data from two previous GWAS. The first study, involving 2,603 participants, identified genetic variants linked to blood copper and zinc levels. The second, much larger study, which included nearly 300,000 participants, focused on genetic variants related to ischemic heart disease and heart attacks.

Results on Copper and Zinc Levels

The initial study revealed three genomic regions associated with copper levels and another three related to zinc levels, accounting for less than 10% of individual variability in metal concentrations. When examining the second study, the researchers found that these genetic variants correlated with ischemic heart disease risk. Specifically, individuals with genetic variants that raised copper levels had a 5% lower likelihood of developing the disease, while those with variants that increased zinc levels had a 5% higher likelihood.

The Significance of the Findings

Though the observed effects may appear modest, the researchers validated their results through multiple statistical analyses, benefiting from the large sample sizes of the GWAS.

Limitations and Future Research

The researchers acknowledged several limitations in their study. It was strictly observational, which means it could not definitively establish causation between copper or zinc levels and ischemic heart disease. Additionally, the majority of participants were of European descent, raising questions about the applicability of the findings to other ethnic groups. There is also the possibility that the genetic variants affecting metal levels may be linked to other biological factors influencing disease risk.

Conclusion

Despite these limitations, the study provides compelling evidence suggesting that copper and zinc levels could influence the risk of ischemic heart disease. While copper supplementation may potentially reduce disease risk, further research is necessary to confirm these findings.

References

Kodali, H. P., Pavilonis, B. T. & Schooling, C. M. Effects of copper and zinc on ischemic heart disease and myocardial infarction: a Mendelian randomization study. Am J Clin Nutr 108, 237-242 (2018).
Finegold, J. A., Asaria, P. & Francis, D. P. Mortality from ischaemic heart disease by country, region, and age: Statistics from World Health Organisation and United Nations. International Journal of Cardiology 168, 934-945 (2013).
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3819990/